|
Volumn 52, Issue 1, 1983, Pages 44-50
|
Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response. A report from the intergroup rhabdomyosarcoma study I
a b c b |
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DACTINOMYCIN;
DOXORUBICIN;
METHOTREXATE;
RAZOXANE;
TENIPOSIDE;
VINCRISTINE;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CHEMOTHERAPY;
CHILD;
CLINICAL ARTICLE;
HUMAN;
METASTASIS;
MUSCLE;
PROGNOSIS;
RELAPSE;
RHABDOMYOSARCOMA;
SOFT TISSUE;
SOFT TISSUE SARCOMA;
THERAPY;
ADOLESCENT;
ADULT;
ANTINEOPLASTIC AGENTS;
CHILD;
CHILD, PRESCHOOL;
DRUG THERAPY, COMBINATION;
FEMALE;
HUMAN;
INFANT;
MALE;
NEOPLASM METASTASIS;
NEOPLASM RECURRENCE, LOCAL;
PROGNOSIS;
SARCOMA;
SOFT TISSUE NEOPLASMS;
SUPPORT, U.S. GOV'T, P.H.S.;
TIME FACTORS;
|
EID: 0020564117
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19830701)52:1<44::AID-CNCR2820520110>3.0.CO;2-V Document Type: Article |
Times cited : (82)
|
References (14)
|